SEC Form 4 · accession 0001209191-17-027437
Axovant Sciences Ltd. · AXON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn E Falberg
Director
Period of report
Apr 17, 2017
Accepted (ET)
Apr 19, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636050
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Apr 17, 2017 | P | 53,937 | $18.54 | A | 53,937 | D |
Table II — derivative securities
No Table II lines on this filing.